Standard BioTools Inc. (LAB)
NASDAQ·Healthcare·Medical - Devices
$0.94
+4.15%
Mkt Cap $350.87M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 24, 2026 | $18.50M | $23.80M | +28.61% | -$0.03 | $0.06 | +300.00% | — | — |
| Q4 2025 Nov 4, 2025 | $18.50M | $19.55M | +5.69% | -$0.03 | -$0.04 | -60.00% | — | — |
| Q3 2025 Aug 11, 2025 | $40.87M | $21.76M | -46.75% | -$0.04 | -$0.04 | +0.00% | — | — |
| Q2 2025 May 6, 2025 | $39.23M | $40.80M | +3.98% | -$0.04 | -$0.04 | +0.00% | — | — |
| Q1 2025 Feb 26, 2025 | $43.03M | $46.72M | +8.56% | -$0.07 | -$0.05 | +28.57% | — | — |
| Q4 2024 Oct 30, 2024 | $43.03M | $44.97M | +4.50% | -$0.08 | -$0.05 | +37.50% | — | — |
| Q3 2024 Jul 31, 2024 | $41.30M | $37.20M | -9.92% | -$0.06 | -$0.08 | -33.33% | — | — |
| Q2 2024 May 8, 2024 | $46.01M | $45.54M | -1.01% | -$0.09 | -$0.23 | -155.56% | — | — |
| Q1 2024 Feb 28, 2024 | $24.90M | $28.19M | +13.20% | -$0.13 | -$0.08 | +38.46% | — | — |
| Q4 2023 Nov 7, 2023 | $23.60M | $25.37M | +7.49% | -$0.12 | -$0.15 | -25.00% | — | — |
| Q3 2023 Aug 8, 2023 | $24.20M | $27.67M | +14.32% | -$0.21 | -$0.14 | +33.33% | — | — |
| Q2 2023 May 9, 2023 | $28.36M | $25.12M | -11.43% | -$0.06 | -$0.11 | -98.77% | — | — |
| Q1 2023 Feb 14, 2023 | $38.00M | $27.02M | -28.89% | -$0.11 | -$0.19 | -72.73% | — | — |
| Q4 2022 Nov 8, 2022 | $30.95M | $25.65M | -17.14% | -$0.13 | -$0.26 | -100.00% | — | — |
| Q3 2022 Aug 8, 2022 | $29.78M | $18.78M | -36.95% | -$0.13 | -$0.33 | -153.85% | — | — |
| Q2 2022 May 5, 2022 | $25.65M | $26.50M | +3.33% | -$0.15 | -$0.25 | -66.67% | — | — |
| Q1 2022 Feb 17, 2022 | $32.67M | $38.27M | +17.11% | -$0.28 | -$0.12 | +57.14% | — | — |
| Q4 2021 Nov 8, 2021 | — | $28.50M | — | -$0.22 | -$0.18 | +18.18% | — | — |
| Q3 2021 Aug 5, 2021 | — | $31.02M | — | -$0.19 | -$0.23 | -21.05% | — | — |
| Q2 2021 May 6, 2021 | — | $32.79M | — | -$0.14 | -$0.25 | -78.57% | — | — |